Susquehanna International Group, LLP Reata Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$79.22 - $105.37 $9.05 Million - $12 Million
-114,300 Reduced 26.14%
322,900 $32.9 Million
Q1 2023

May 16, 2023
BUY
$30.85 - $93.17 $5.66 Million - $17.1 Million
183,600 Added 72.4%
437,200 $39.8 Million
Q4 2022

Feb 14, 2023
BUY
$22.15 - $42.11 $1.79 Million - $3.41 Million
80,900 Added 46.84%
253,600 $9.63 Million
Q3 2022

Nov 14, 2022
BUY
$19.41 - $36.49 $1.43 Million - $2.69 Million
73,600 Added 74.27%
172,700 $4.34 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email